GR79429B - - Google Patents

Info

Publication number
GR79429B
GR79429B GR72935A GR830172935A GR79429B GR 79429 B GR79429 B GR 79429B GR 72935 A GR72935 A GR 72935A GR 830172935 A GR830172935 A GR 830172935A GR 79429 B GR79429 B GR 79429B
Authority
GR
Greece
Application number
GR72935A
Other languages
Greek (el)
Inventor
G D Smith
D S Brown
P Bernstein
J E Weller
Original Assignee
Inco Res & Dev Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inco Res & Dev Center Inc filed Critical Inco Res & Dev Center Inc
Publication of GR79429B publication Critical patent/GR79429B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0013Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR72935A 1982-11-10 1983-11-09 GR79429B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44044982A 1982-11-10 1982-11-10
US06/540,871 US4584392A (en) 1982-11-10 1983-10-14 Platinum and palladium complexes

Publications (1)

Publication Number Publication Date
GR79429B true GR79429B (en:Method) 1984-10-22

Family

ID=27032420

Family Applications (1)

Application Number Title Priority Date Filing Date
GR72935A GR79429B (en:Method) 1982-11-10 1983-11-09

Country Status (11)

Country Link
US (1) US4584392A (en:Method)
EP (1) EP0111388B1 (en:Method)
AU (1) AU566785B2 (en:Method)
CA (1) CA1227133A (en:Method)
DE (1) DE3370485D1 (en:Method)
ES (1) ES527111A0 (en:Method)
FI (1) FI81006C (en:Method)
GR (1) GR79429B (en:Method)
IE (1) IE56211B1 (en:Method)
NO (1) NO163693C (en:Method)
PT (1) PT77635B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673754A (en) * 1983-10-14 1987-06-16 Inco Alloys International, Inc. Platinum and palladium complexes
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
CS253069B1 (en) * 1984-11-09 1987-10-15 Jaroslav Drobnik Macromolecular anticarcinogenetic remedy containing platinum and method of its production
IL73972A0 (en) * 1984-12-31 1985-03-31 Yeda Res & Dev Agents based on platinum compounds
AU7481487A (en) * 1986-05-21 1987-12-22 Kuraray Co., Ltd. Novel complexes, process for their preparation, and medicinal use of them
US5011959A (en) * 1986-11-17 1991-04-30 The Board Of Regents, The University Of Texas System 1,2-diaminocyclohexane-platinum complexes with antitumor activity
EP0284197A1 (en) * 1987-02-20 1988-09-28 Tanabe Seiyaku Co., Ltd. Novel organic platinum complex and process for the preparation thereof
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
IL85595A0 (en) * 1987-03-06 1988-08-31 Tanabe Seiyaku Co Organic platinum complex and its preparation
ATE129254T1 (de) * 1987-03-19 1995-11-15 Arthropharm Pty Ltd Antientzündungsmittel und zusammensetzungen.
EP0307827A3 (en) * 1987-09-15 1989-12-27 Kuraray Co., Ltd. Novel macromolecular complexes, process for producing same and medicinal use of such complexes
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5352771A (en) * 1992-08-31 1994-10-04 Iowa State University Research Foundation Inc. Hydrolysis of peptide bonds using Pt (II) and Pd (II) complexes
US20070148721A1 (en) * 2005-12-28 2007-06-28 Agilent Technologies, Inc. Compositions, methods, systems, and kits for affinity purification
EP3577123B1 (de) * 2018-02-06 2020-04-15 Wacker Chemie AG Verfahren zur herstellung von aminopropylalkoxysilanen
CN113995714B (zh) 2021-10-28 2023-04-28 杭州师范大学 一种顺铂交联的蛋白水凝胶及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (en:Method) * 1972-06-08 1977-06-15 Research Corp
GB1531211A (en) * 1975-10-27 1978-11-08 Rustenburg Platinum Mines Ltd Compounds and compositions containing platinum
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4376782A (en) * 1980-05-21 1983-03-15 Research Corporation Complexes of square planar platinum II compounds and N-methyl glucamine
JPS5851959B2 (ja) * 1980-06-11 1983-11-19 呉羽化学工業株式会社 プラチナ化合物とその医薬組成物

Also Published As

Publication number Publication date
IE832614L (en) 1984-05-10
ES8504631A1 (es) 1985-05-01
EP0111388B1 (en) 1987-03-25
AU566785B2 (en) 1987-10-29
EP0111388A2 (en) 1984-06-20
DE3370485D1 (en) 1987-04-30
FI834129A0 (fi) 1983-11-10
FI81006B (fi) 1990-05-31
FI834129L (fi) 1984-05-11
IE56211B1 (en) 1991-05-22
PT77635B (en) 1986-03-19
ES527111A0 (es) 1985-05-01
NO834089L (no) 1984-05-11
PT77635A (en) 1983-12-01
EP0111388A3 (en) 1984-09-05
AU2110983A (en) 1984-05-17
NO163693B (no) 1990-03-26
NO163693C (no) 1990-07-04
US4584392A (en) 1986-04-22
CA1227133A (en) 1987-09-22
FI81006C (fi) 1990-09-10

Similar Documents

Publication Publication Date Title
DE3374522D1 (en:Method)
CH655511B (en:Method)
CH655656B (en:Method)
CH655644B (en:Method)
CH646569GA3 (en:Method)
FR2519583B1 (en:Method)
DE3376194T2 (en:Method)
FR2519260B3 (en:Method)
FR2519521B1 (en:Method)
GR79429B (en:Method)
CH655495B (en:Method)
FR2519470B1 (en:Method)
FR2519556B3 (en:Method)
CH655391B (en:Method)
FR2519842B3 (en:Method)
FR2519673B1 (en:Method)
FR2520063B3 (en:Method)
DE3374913T (en:Method)
DE3375677T (en:Method)
CH655449B (en:Method)
FR2519543B1 (en:Method)
FR2519660B1 (en:Method)
FR2519361B1 (en:Method)
FR2519600B1 (en:Method)
FR2519303B1 (en:Method)